NCT04130555View on ClinicalTrials.gov

Safety and Performance Evaluation of a Biological Matrix Used for Rectal Prolapse Repair by Ventral Rectopexy

CompletedOBSERVATIONAL
Enrollment

55

Participants

Timeline

Start Date

December 11, 2019

Primary Completion Date

October 26, 2023

Study Completion Date

October 26, 2023

Conditions
Rectal Prolapse
Interventions
DEVICE

CELLIS Rectopexy (Porcine Acellular Dermal Matrix, PADM)

Biological membrane used in Laparoscopic Ventral Rectopexy (LVR) or robotic assisted rectopexy

Trial Locations (3)

63 003

CHU Estaing, Clermont-Ferrand

44 093

CHU Nantes Hôtel Dieu, Nantes

33 604

Hôpital Haut-Lévèque- CHU de Bordeaux, Pessac

Sponsors

Lead Sponsor

Meccellis Biotech
All Listed Sponsors
lead

Meccellis Biotech

INDUSTRY

NCT04130555 - Safety and Performance Evaluation of a Biological Matrix Used for Rectal Prolapse Repair by Ventral Rectopexy | Biotech Hunter | Biotech Hunter